New depression pill begins first human safety tests
NCT ID NCT07371065
Summary
This early-stage study is testing a new tablet called LY03021 for depression. Researchers are checking how safe it is and how the body processes it in 98 healthy volunteers. They're also seeing if taking the pill with food makes a difference in how it works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
No. 604 Lingling Road, Shanghai
Shanghai, China
Conditions
Explore the condition pages connected to this study.